id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0823-0011,FDA,FDA-2013-N-0823,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2020-01-30T05:00:00Z,2020,1,2020-01-30T05:00:00Z,,2020-01-30T17:29:56Z,2020-01655,0,0,090000648430c604
FDA-2013-N-0823-0010,FDA,FDA-2013-N-0823,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Format and Content Requirements for Over-the-Counter Drug Product Labeling,Notice,30 Day Proposed Information Collection,2019-11-12T05:00:00Z,2019,11,2019-11-12T05:00:00Z,2019-12-13T04:59:59Z,2019-11-12T13:53:50Z,2019-24509,0,0,0900006484142c5e
FDA-2013-N-0823-0008,FDA,FDA-2013-N-0823,Agency Information Collection Activities; Proposed Collection; Comment Request; Format and Content Requirements for Over-the- Counter Drug Product Labeling,Notice,60 Day Proposed Information Collection,2019-06-19T04:00:00Z,2019,6,2019-06-19T04:00:00Z,2019-08-20T03:59:59Z,2019-10-22T20:26:43Z,2019-12996,0,0,0900006483d238a7
FDA-2013-N-0823-0007,FDA,FDA-2013-N-0823,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2017-05-30T04:00:00Z,2017,5,2017-05-30T04:00:00Z,,2017-05-30T14:32:33Z,2017-11011,0,0,0900006482667fb4
FDA-2013-N-0823-0005,FDA,FDA-2013-N-0823,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Format and
Content Requirements for Over-the-Counter Drug Product Labeling",Notice,30 Day Proposed Information Collection,2016-10-26T04:00:00Z,2016,10,2016-10-26T04:00:00Z,2016-11-26T04:59:59Z,2016-11-20T14:00:34Z,2016-25854,0,0,090000648234d49e
FDA-2013-N-0823-0004,FDA,FDA-2013-N-0823,Agency Information Collection Activities; Proposed Collection; Comment Request; Format and Content Requirements for Over-the-Counter Drug Product Labeling,Notice,60 Day Proposed Information Collection,2016-04-01T04:00:00Z,2016,4,2016-04-01T04:00:00Z,2016-06-01T03:59:59Z,2016-10-18T18:13:40Z,2016-07369,0,0,0900006481f09282
FDA-2013-N-0823-0003,FDA,FDA-2013-N-0823,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; Over-the-Counter Human Drugs;
Labeling Requirements",Notice,Notice of Approval,2014-02-18T05:00:00Z,2014,2,2014-02-18T05:00:00Z,,2014-12-13T20:42:09Z,2014-03348,0,0,09000064815768e0
FDA-2013-N-0823-0002,FDA,FDA-2013-N-0823,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Over-the-Counter Drugs; Labeling Requirements,Notice,30 Day Proposed Information Collection,2013-12-05T05:00:00Z,2013,12,2013-12-05T05:00:00Z,2014-01-07T04:59:59Z,2013-12-08T15:37:58Z,2013-29079,0,0,09000064814a9e18
FDA-2013-N-0823-0001,FDA,FDA-2013-N-0823,Agency Information Collection Activities: Proposed Collection; Comment Request; Format and Content Requirements for Over-the-Counter Drug Product Labeling,Notice,60 Day Proposed Information Collection,2013-07-23T04:00:00Z,2013,7,2013-07-23T04:00:00Z,2013-09-24T03:59:59Z,2013-12-08T15:39:05Z,2013-17548,0,0,09000064813761d3